Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1524) 1524
Book Review (149) 149
Publication (90) 90
Book Chapter (14) 14
Book / eBook (7) 7
Conference Proceeding (6) 6
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1367) 1367
actinobacteria (774) 774
bacteria (753) 753
microbiology (654) 654
humans (511) 511
research article (437) 437
biology and life sciences (396) 396
organisms (393) 393
medicine (365) 365
medicine and health sciences (359) 359
multidisciplinary sciences (344) 344
tuberculosis (343) 343
research (330) 330
analysis (329) 329
science (324) 324
actinobacteria - metabolism (318) 318
mycobacterium tuberculosis (312) 312
animals (311) 311
infectious diseases (311) 311
biotechnology & applied microbiology (294) 294
actinobacteria - genetics (290) 290
antibiotics (275) 275
phylogeny (249) 249
bacterial diseases (248) 248
tropical diseases (244) 244
female (239) 239
actinobacteria - isolation & purification (238) 238
immunology (228) 228
infections (212) 212
anti-bacterial agents - pharmacology (207) 207
male (206) 206
studies (205) 205
actinobacteria - chemistry (202) 202
microbial sensitivity tests (202) 202
life sciences (193) 193
actinobacteria - drug effects (190) 190
research and analysis methods (190) 190
biotechnology (182) 182
rna, ribosomal, 16s - genetics (181) 181
physiological aspects (180) 180
actinomycetes (178) 178
biosynthesis (174) 174
metabolites (173) 173
diversity (169) 169
biochemistry (168) 168
proteins (168) 168
soil microbiology (164) 164
streptomyces (164) 164
drug resistance (161) 161
physiology (159) 159
actinobacteria - classification (156) 156
adult (156) 156
microorganisms (156) 156
pathogens (150) 150
cell biology (149) 149
enzymes (142) 142
identification (138) 138
health aspects (137) 137
genetics (131) 131
genetic aspects (129) 129
biology (127) 127
laboratories (127) 127
genes (126) 126
middle aged (123) 123
sequence analysis, dna (123) 123
patients (122) 122
molecular sequence data (120) 120
medical microbiology (119) 119
mice (119) 119
pathology and laboratory medicine (119) 119
diagnostic medicine (118) 118
pharmacology & pharmacy (117) 117
natural-products (116) 116
diagnosis (115) 115
pharmacology (115) 115
molecular biology (113) 113
dna, bacterial - genetics (111) 111
genomics (108) 108
risk factors (105) 105
bacteria - drug effects (104) 104
rna (102) 102
biochemistry & molecular biology (101) 101
chemistry (101) 101
gene expression (101) 101
care and treatment (100) 100
public health (99) 99
drugs (96) 96
animal cells (94) 94
cellular types (94) 94
gene (94) 94
immune cells (93) 93
anti-bacterial agents - chemistry (92) 92
bacterial proteins - genetics (92) 92
chemistry, medicinal (92) 92
physical sciences (92) 92
fermentation (91) 91
metabolism (90) 90
natural products (90) 90
actinobacteria - physiology (89) 89
bacterial proteins - metabolism (89) 89
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1515) 1515
Chinese (8) 8
Russian (8) 8
French (2) 2
Spanish (2) 2
Bulgarian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
by Henry J. Haiser and David B. Gootenberg and Kelly Chatman and Gopal Sirasani and Emily P. Balskus and Peter J. Turnbaugh
Science, ISSN 0036-8075, 7/2013, Volume 341, Issue 6143, pp. 295 - 298
Despite numerous examples of the effects of the human gastrointestinal microbiome on drug efficacy and toxicity, there is often an incomplete understanding of... 
Statistical significance | Urine | Microbiota | Efficiency loss | Medical treatment | REPORTS | Dietary protein | Operons | Pharmacology | Sequencing | T tests | FLORA | MULTIDISCIPLINARY SCIENCES | DIGOXIN | Humans | Gastrointestinal Tract - microbiology | Transcriptome - drug effects | Cytochromes - genetics | Mice, Inbred Strains | Operon - genetics | Actinobacteria - drug effects | Digoxin - pharmacokinetics | Feces - microbiology | Gene Expression Regulation, Bacterial - drug effects | Animals | Operon - drug effects | Arginine - pharmacology | Dietary Proteins - pharmacology | Actinobacteria - genetics | Germ-Free Life | Actinobacteria - metabolism | Digoxin - urine | Mice | Digoxin - blood | Metagenome | Actinomycetes | Research | Digoxin | Microbiota (Symbiotic organisms) | Pharmacokinetics | Health aspects | Proteins | Bacteria | Metabolites | Cardiology | Drug therapy | Rodents | Index Medicus | Diets | Human | Drugs | Effectiveness | Abnormalities | Glycosides | Inactivation | Strain
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text High-Throughput Sequencing Reveals the Incomplete, Short-Term Recovery of Infant Gut Microbiota following Parenteral Antibiotic Treatment with Ampicillin and Gentamicin
by Fiona Fouhy and Caitriona M. Guinane and Seamus Hussey and Rebecca Wall and C. Anthony Ryan and Eugene M. Dempsey and Brendan Murphy and R. Paul Ross and Gerald F. Fitzgerald and Catherine Stanton and Paul D. Cotter
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2012, Volume 56, Issue 11, pp. 5811 - 5820
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
MOLECULAR CHARACTERIZATION | HOSPITALIZED-PATIENTS | INTESTINAL MICROBIOTA | DELIVERY MODE | FECAL MICROBIOTA | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | PRETERM INFANTS | DIVERSITY | BACTERIAL | IMPACTS | EXPOSURE | Lactobacillus - genetics | Humans | Infant | Male | Colony Count, Microbial | Proteobacteria - genetics | Actinobacteria - drug effects | Feces - microbiology | Lactobacillus - drug effects | Actinobacteria - genetics | Polymerase Chain Reaction | Recovery of Function - physiology | Female | Anti-Bacterial Agents - adverse effects | Metagenome - drug effects | Gentamicins - adverse effects | Bifidobacterium - genetics | Ampicillin - adverse effects | Gastrointestinal Tract - microbiology | Infusions, Parenteral | Gastrointestinal Tract - drug effects | DNA Primers | Proteobacteria - drug effects | Bifidobacterium - drug effects | RNA, Ribosomal, 16S - genetics | High-Throughput Nucleotide Sequencing | Index Medicus | Clinical Therapeutics | Biological Sciences | Naturvetenskap | Medical and Health Sciences | Microbiology | Medicin och hälsovetenskap | Biologiska vetenskaper | Mikrobiologi | Natural Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Chemotherapy‐driven dysbiosis in the intestinal microbiome
by Montassier, E and Gastinne, T and Vangay, P and Al‐Ghalith, G. A and Bruley des Varannes, S and Massart, S and Moreau, P and Potel, G and La Cochetière, M. F and Batard, E and Knights, D
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 09/2015, Volume 42, Issue 5, pp. 515 - 528
BackgroundChemotherapy is commonly used as myeloablative conditioning treatment to prepare patients for haematopoietic stem cell transplantation (HSCT).... 
BLOOD-STREAM INFECTION | INFLAMMATION | FECAL MICROBIOTA | BARRIER FUNCTION | PHARMACOLOGY & PHARMACY | FATTY-ACIDS | HIGH-DOSE CHEMOTHERAPY | GUT MICROBIOTA | STEM-CELL TRANSPLANTATION | GASTROENTEROLOGY & HEPATOLOGY | CANCER | INDUCED GASTROINTESTINAL MUCOSITIS | RNA, Ribosomal, 16S - metabolism | Mucositis - metabolism | Dysbiosis - chemically induced | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Dysbiosis - microbiology | Proteobacteria - drug effects | Actinobacteria - drug effects | Mucositis - chemically induced | Dysbiosis - metabolism | Feces - microbiology | Gastrointestinal Microbiome - drug effects | Mucositis - microbiology | Antineoplastic Agents - adverse effects | Lymphoma, Non-Hodgkin - therapy | Adult | Female | High-Throughput Nucleotide Sequencing | Hematopoietic Stem Cell Transplantation - methods | Firmicutes - drug effects | RNA, Ribosomal, 16S - drug effects | Lymphoma, Non-Hodgkin - drug therapy | Biodegradation | Chemotherapy | Microbiota (Symbiotic organisms) | Analysis | Transplantation | Hematopoietic stem cells | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis
by Wallace, John L and Syer, Stephanie and Denou, Emmanuel and de Palma, Giada and Vong, Linda and McKnight, Webb and Jury, Jennifer and Bolla, Manlio and Bercik, Premysl and Collins, Stephen M and Verdu, Elena and Ongini, Ennio
Gastroenterology, ISSN 0016-5085, 2011, Volume 141, Issue 4, pp. 1314 - 1322.e5
Background & Aims Proton pump inhibitors (PPIs) and nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used classes of drugs, with the... 
Gastroenterology and Hepatology | Ulcer | Microflora | Bleeding | Acid Secretion | ULCERS | NONSTEROIDAL ANTIINFLAMMATORY DRUG | PERMEABILITY | RATS | INDOMETHACIN | LEUKOCYTE ADHERENCE | INDUCED GASTRIC DAMAGE | PATHOGENESIS | NITRIC-OXIDE | BACTERIAL OVERGROWTH | GASTROENTEROLOGY & HEPATOLOGY | Jejunum - pathology | Rats, Wistar | Colon - drug effects | Hematocrit | Peptic Ulcer - prevention & control | Male | Omeprazole - toxicity | Bifidobacterium - isolation & purification | Bifidobacterium - growth & development | Actinobacteria - drug effects | Jejunum - drug effects | Drug Interactions | Peptic Ulcer - microbiology | Time Factors | Actinobacteria - genetics | Actinobacteria - isolation & purification | Disease Models, Animal | Bifidobacterium - genetics | Jejunum - microbiology | Rats | Celecoxib | Probiotics - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Proton Pump Inhibitors - toxicity | Anti-Inflammatory Agents, Non-Steroidal - toxicity | Peptic Ulcer - pathology | Denaturing Gradient Gel Electrophoresis | 2-Pyridinylmethylsulfinylbenzimidazoles - toxicity | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Bifidobacterium - drug effects | Animals | Gastrointestinal Hemorrhage - microbiology | Actinobacteria - growth & development | Pyrazoles - toxicity | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Naproxen - toxicity | Sulfonamides - toxicity | Colon - microbiology | Peptic Ulcer - chemically induced | Gastrointestinal Hemorrhage - pathology | Lansoprazole | Proton pump inhibitors | Messenger RNA | Nonsteroidal anti-inflammatory drugs | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Bromochloromethane, a methane analogue, affects the microbiota and metabolic profiles of the rat gastrointestinal tract
by Yang, Yu-Xiang and Mu, Chun-Long and Luo, Zhen and Zhu, Wei-Yun
Applied and Environmental Microbiology, ISSN 0099-2240, 2016, Volume 82, Issue 3, pp. 778 - 787
Bromochloromethane (BCM), an inhibitor of methanogenesis, has been used in animal production. However, little is known about its impact on the intestinal... 
AMINO-ACID-METABOLISM | GEL-ELECTROPHORESIS ANALYSIS | METHANOGENIC BACTERIA | DIETARY-PROTEIN | RUMEN FERMENTATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | BIOGENIC-AMINES | MICROBIOLOGY | SP-NOV | HYDROGEN-SULFIDE | GUT MICROBIOTA | SULFATE-REDUCING BACTERIA | Intestines - drug effects | Carbohydrate Metabolism - drug effects | Proteobacteria - metabolism | Rats, Wistar | Gastrointestinal Microbiome - physiology | Intestines - metabolism | Cecum - microbiology | Proteobacteria - genetics | Actinobacteria - drug effects | Euryarchaeota - genetics | Cecum - metabolism | Actinobacteria - genetics | Actinobacteria - metabolism | Acidobacteria - genetics | Hydrocarbons, Halogenated - pharmacology | Euryarchaeota - classification | RNA, Ribosomal, 16S - metabolism | Gastrointestinal Tract - microbiology | Gastrointestinal Tract - drug effects | Acidobacteria - metabolism | Fermentation | Gastrointestinal Microbiome - genetics | Euryarchaeota - drug effects | Proteobacteria - drug effects | Sequence Analysis, DNA | Cecum - drug effects | Metabolome - genetics | Animals | Gastrointestinal Microbiome - drug effects | Intestines - microbiology | Euryarchaeota - metabolism | Metabolome - drug effects | Lipid Metabolism - drug effects | Acidobacteria - drug effects | Hydrocarbons, Halogenated - administration & dosage | Microbiota (Symbiotic organisms) | Gastrointestinal system | Analysis | Rattus | Rats | Genetic aspects | Research | Methane | Microorganisms | Metabolism | Digestive system | Rodents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Dissemination of antibiotic resistance genes from antibiotic producers to pathogens
by Jiang, Xinglin and Ellabaan, Mostafa M. Hashim and Charusanti, Pep and Munck, Christian and Blin, Kai and Tong, Yaojun and Weber, Tilmann and Sommer, Morten O.A and Lee, Sang Yup
Nature Communications, ISSN 2041-1723, 06/2017, Volume 8, Issue 1, pp. 15784 - 15784
It has been hypothesized that some antibiotic resistance genes (ARGs) found in pathogenic bacteria derive from antibiotic-producing actinobacteria. Here we... 
TRANSFORMATION | RESISTOMES | PHYLOGENY | STREPTOMYCES | DATABASE | CLUSTERS | MULTIDISCIPLINARY SCIENCES | ESCHERICHIA-COLI | HABITATS | RESOURCE | Streptomyces - genetics | Bacterial Proteins - genetics | Acinetobacter - genetics | Anti-Bacterial Agents - metabolism | Gene Transfer, Horizontal | Drug Resistance, Microbial - genetics | Phylogeny | Proteobacteria - drug effects | Proteobacteria - genetics | Acinetobacter - drug effects | Actinobacteria - drug effects | DNA Transposable Elements | Proteobacteria - pathogenicity | Escherichia coli - genetics | Actinobacteria - genetics | Anti-Bacterial Agents - pharmacology | Streptomyces - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Endophytic actinobacteria induce defense pathways in Arabidopsis thaliana
by Conn, V.M and Walker, A.R and Franco, Chris M. M
Molecular Plant-Microbe Interactions, ISSN 0894-0282, 02/2008, Volume 21, Issue 2, pp. 208 - 218
Endophytic actinobacteria, isolated from healthy wheat tissue, which are capable of suppressing a number wheat fungal pathogens both in vitro and in planta,... 
BIOCHEMISTRY & MOLECULAR BIOLOGY | FUSARIUM-OXYSPORUM | ACQUIRED-RESISTANCE | INDUCED DISEASE RESISTANCE | PLANT SCIENCES | SALICYLIC-ACID | PSEUDOMONAS-FLUORESCENS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | WALL-DEGRADING ENZYMES | GENE-EXPRESSION | INDUCED SYSTEMIC RESISTANCE | PATHOGENESIS-RELATED PROTEINS | ERWINIA-CAROTOVORA | Genes, Plant | Plant Diseases - immunology | Immunity, Innate - genetics | Arabidopsis - immunology | Fusarium - drug effects | Plant Diseases - microbiology | RNA, Messenger - metabolism | Streptomyces - immunology | Actinobacteria - drug effects | Plant Diseases - genetics | Actinobacteria - physiology | Ethylenes - pharmacology | Pectobacterium carotovorum - immunology | Arabidopsis - drug effects | Immunity, Innate - drug effects | RNA, Messenger - genetics | Cyclopentanes - pharmacology | Mutation - genetics | Pectobacterium carotovorum - drug effects | Arabidopsis - genetics | Arabidopsis - microbiology | Immunity, Innate - immunology | Fusarium - immunology | Gene Expression Regulation, Plant - drug effects | Oxylipins - pharmacology | Streptomyces - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Bacteria Subsisting on Antibiotics
by Gautam Dantas and Morten O. A. Sommer and Rantimi D. Oluwasegun and George M. Church
Science, ISSN 0036-8075, 4/2008, Volume 320, Issue 5872, pp. 100 - 103
Antibiotics are a crucial line of defense against bacterial infections. Nevertheless, several antibiotics are natural products of microorganisms that have as... 
Pathogens | Microorganisms | Agricultural soils | Databases | Antibiotics | Penicillin | Bacteria | Reports | Acid soils | Soil pollution | Soil bacteria | RESISTOME | ARB | RESISTANCE GENES | BENZYLPENICILLIN | CARBON | DATABASE | MULTIDISCIPLINARY SCIENCES | NITROGEN | SOIL | DIVERSITY | MOLECULAR-MECHANISMS | Bacteroidetes - isolation & purification | Proteobacteria - metabolism | Soil Microbiology | Drug Resistance, Bacterial | Molecular Sequence Data | Anti-Bacterial Agents - metabolism | Carbenicillin - metabolism | Bacteroidetes - drug effects | Phylogeny | Proteobacteria - drug effects | Actinobacteria - drug effects | Penicillins - metabolism | Proteobacteria - isolation & purification | Bacteroidetes - metabolism | Actinobacteria - growth & development | Actinobacteria - metabolism | Bacteroidetes - growth & development | Actinobacteria - isolation & purification | Anti-Bacterial Agents - pharmacology | Proteobacteria - growth & development | Ciprofloxacin - metabolism | Drug resistance in microorganisms | Evaluation | Microbial genetics | Research | Properties | Soil microbiology | Microbiology | Drug resistance | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Identifying producers of antibacterial compounds by screening for antibiotic resistance
by Thaker, Maulik N and Wang, Wenliang and Spanogiannopoulos, Peter and Waglechner, Nicholas and King, Andrew M and Medina, Ricardo and Wright, Gerard D
Nature Biotechnology, ISSN 1087-0156, 10/2013, Volume 31, Issue 10, pp. 922 - 927
Microbially derived natural products are major sources of antibiotics and other medicines, but discovering new antibiotic scaffolds and increasing the chemical... 
RESISTOME | BIOSYNTHETIC GENE-CLUSTER | STREPTOMYCES | CLONING | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | NATURAL-PRODUCTS | VANCOMYCIN RESISTANCE | DIVERSITY | PIPELINE | IDENTIFICATION | Drug Evaluation, Preclinical - methods | Reproducibility of Results | Drug Resistance, Microbial - drug effects | Rifampin - chemistry | Glycopeptides - chemistry | Glycopeptides - isolation & purification | Anti-Bacterial Agents - isolation & purification | Phylogeny | Actinobacteria - chemistry | Actinobacteria - drug effects | Vancomycin - chemistry | Biosynthetic Pathways - drug effects | Anti-Bacterial Agents - chemistry | Vancomycin - pharmacology | Glycopeptides - biosynthesis | Anti-Bacterial Agents - biosynthesis | Anti-Bacterial Agents - pharmacology | Vancomycin - isolation & purification | Rifampin - pharmacology | Glycopeptides - pharmacology | Drug resistance in microorganisms | Synthetic biology | Research | Peptides | Properties | Antibacterial agents | Antimicrobial agents | Biosynthesis | Microbiology | Drug resistance | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Oral imazalil exposure induces gut microbiota dysbiosis and colonic inflammation in mice
by Jin, Yuanxiang and Jin, Cuiyuan and Zeng, Zhaoyang and Fu, Zhengwei
Chemosphere, ISSN 0045-6535, 10/2016, Volume 160, pp. 349 - 358
The fungicide imazalil (IMZ) is used extensively in vegetable and fruit plantations and as a post-harvest treatment to avoid rot. Here, we revealed that... 
Gut microbiota | Mice | Imazalil | Colonic inflammation | OXIDATIVE STRESS | CROHNS-DISEASE | ZEBRAFISH DANIO-RERIO | IMMUNOTOXICITY | ULCERATIVE-COLITIS | INCREASES | LOCOMOTOR-ACTIVITY | CADMIUM II | CHROMIUM VI | ENVIRONMENTAL SCIENCES | MOUSE MODEL | Liver - pathology | Liver - enzymology | Humans | Colon - drug effects | Fungicides, Industrial - toxicity | Colon - immunology | Male | Dysbiosis - microbiology | Proteobacteria - genetics | Actinobacteria - drug effects | Dysbiosis - immunology | Feces - microbiology | Liver - drug effects | Actinobacteria - genetics | Tumor Necrosis Factor-alpha - immunology | Imidazoles - toxicity | Dysbiosis - chemically induced | Colon - pathology | Bacteroidetes - drug effects | Gastrointestinal Microbiome - genetics | Proteobacteria - drug effects | Animals | Gastrointestinal Microbiome - drug effects | RNA, Ribosomal, 16S - genetics | Colon - microbiology | Bacteroidetes - genetics | Inflammation | Microbiota (Symbiotic organisms) | RNA | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text In vitro activities of pexiganan and 10 comparator antimicrobials against 502 anaerobic isolates recovered from skin and skin structure infections
by Goldstein, Ellie J. C and Citron, Diane M and Tyrrell, Kerin L and Leoncio, Eliza S
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2017, Volume 61, Issue 12
Pexiganan, a cationic peptide, exhibited a broad range of anti-anaerobic antimicrobial activity. The MIC90s of studied isolates were as follows: Bacteroides... 
Pexiganan | Finegoldia magna | Anaerobes | Topical antimicrobials | Bacteroides fragilis | Propionibacterium acnes | Clostridia | Wound infections | clostridia | BACTERIOLOGY | pexiganan | wound infections | DIABETIC FOOT INFECTIONS | topical antimicrobials | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | anaerobes | Peptostreptococcus - drug effects | Skin - microbiology | Porphyromonas - drug effects | Propionibacterium acnes - growth & development | United States | Humans | Bacteroides fragilis - drug effects | Actinobacteria - drug effects | Clostridium perfringens - isolation & purification | Fusobacterium - drug effects | Microbial Sensitivity Tests | Skin Diseases, Infectious - microbiology | Sweden | Prevotella - growth & development | Bacteroides fragilis - growth & development | Actinobacteria - isolation & purification | Porphyromonas - isolation & purification | Fusobacterium - growth & development | Skin - pathology | Firmicutes - growth & development | Amino Acid Sequence | Antimicrobial Cationic Peptides - chemical synthesis | Anaerobiosis - physiology | Firmicutes - isolation & purification | Skin Diseases, Infectious - pathology | Antimicrobial Cationic Peptides - pharmacology | Peptostreptococcus - isolation & purification | Prevotella - drug effects | Anti-Bacterial Agents - chemical synthesis | Bacteroides fragilis - isolation & purification | Canada | Clostridium perfringens - drug effects | Peptostreptococcus - growth & development | Clostridium perfringens - growth & development | Actinobacteria - growth & development | Propionibacterium acnes - isolation & purification | Anti-Bacterial Agents - pharmacology | Porphyromonas - growth & development | Firmicutes - drug effects | Prevotella - isolation & purification | Propionibacterium acnes - drug effects | Fusobacterium - isolation & purification | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Eliciting antibiotics active against the ESKAPE pathogens in a collection of actinomycetes isolated from mountain soils
by Zhu, Hua and Swierstra, Jasper and Wu, Changsheng and Girard, Geneviéve and Choi, Young Hae and Van Wamel, Willem and Sandiford, Stephanie K and van Wezel, Gilles P
Microbiology (United Kingdom), ISSN 1350-0872, 2014, Volume 160, Issue 8, pp. 1714 - 1726
The rapid emergence of multidrug-resistant (MDR) bacterial pathogens poses a major threat for human health. In recent years, genome sequencing has unveiled... 
SECONDARY METABOLISM | GENOME SEQUENCE | REGULATOR DASR | RESISTOMYCIN | STREPTOMYCES-COELICOLOR | LINKS | MICROBIOLOGY | ANTIBACTERIAL DISCOVERY | MODEL | RESISTANT STAPHYLOCOCCUS-AUREUS | EPIDEMIOLOGY | Enterobacter cloacae - drug effects | Enterococcus faecium - drug effects | Klebsiella pneumoniae - drug effects | Soil Microbiology | Humans | Molecular Sequence Data | Anti-Bacterial Agents - metabolism | Actinobacteria - classification | Pseudomonas aeruginosa - drug effects | Microbial Sensitivity Tests | Anti-Bacterial Agents - chemistry | China | Drug Resistance, Multiple, Bacterial | Actinobacteria - genetics | Actinobacteria - metabolism | Actinobacteria - isolation & purification | Anti-Bacterial Agents - pharmacology | Acinetobacter baumannii - drug effects | Staphylococcus aureus - drug effects | Bacterial Infections - microbiology | Usage | Pathogenic microorganisms | Antibiotics | Analysis | Actinomycetes | Genetic aspects | Research | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response
by Zakostelska, Z and Malkova, J and Klimesova, K and Rossmann, P and Hornova, M and Novosadova, I and Stehlikova, Z and Kostovcik, M and Hudcovic, T and Stepankova, R and Juzlova, K and Hercogova, J and Tlaskalova-Hogenova, H and Kverka, M
PLOS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, pp. e0159539 - e0159539
Psoriasis is a chronic inflammatory skin disease in which Th17 cells play a crucial role. Since indigenous gut microbiota influences the development and... 
MUCOSAL BARRIER | DIET | ALTERED GUT MICROBIOTA | MULTIDISCIPLINARY SCIENCES | DISEASE | PROBIOTICS | BACTERIAL OVERGROWTH | ROSACEA | GERM-FREE | T-CELLS | MANIFESTATIONS | Skin - microbiology | Species Specificity | Humans | Interleukin-17 - immunology | Receptors, Antigen, T-Cell, gamma-delta - genetics | Gastrointestinal Microbiome - physiology | Actinobacteria - drug effects | Clostridiales - drug effects | Th17 Cells - drug effects | Lactobacillales - physiology | Psoriasis - pathology | Female | Actinobacteria - physiology | Aminoquinolines - pharmacology | Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics | Skin - pathology | Disease Models, Animal | Skin - immunology | Psoriasis - immunology | Nuclear Receptor Subfamily 1, Group F, Member 3 - immunology | Gene Expression | Clostridiales - physiology | Mice, Inbred C57BL | Interleukin-17 - genetics | Psoriasis - microbiology | Receptors, Antigen, T-Cell, gamma-delta - immunology | Animals | Gastrointestinal Microbiome - drug effects | Lactobacillales - drug effects | Lymphocyte Activation - drug effects | Psoriasis - chemically induced | Germ-Free Life | Th17 Cells - immunology | Anti-Bacterial Agents - pharmacology | Mice | Mice, Inbred BALB C | Skin - drug effects | Th17 Cells - microbiology | Animal experimentation | Antibiotics | Microbiota (Symbiotic organisms) | Psoriasis | Dosage and administration | Research | Drug therapy | Health aspects | Risk factors | Drinking water | Animal models | Imiquimod | Helper cells | Lymphocytes T | Arthritis | Skin resistance | Experiments | Inflammatory diseases | Microbiota | Lymphocytes | Intestine | Skin diseases | Bacteria | Intestinal microflora | Lesions | Digestive tract | Systems development | Rosacea | Immune system | Medical research | Gnotobiotics | Dermatology | Digestive system | Acne | Inflammation | Inflammatory bowel disease | Immune systems | Probiotics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights